NCT04608175

Brief Summary

Background: Breast cancer is one of the most prevalent cancers worldwide. Fortunately, survival has improved in recent years thanks to its early detection and curative treatments such as mastectomy. However, this medical procedure is associated with a range of unwanted effects such as postoperative pain and anxiety. Some studies have reported that acupuncture could be an effective treatment to control these types of symptoms, although only few studies have been conducted on women undergoing mastectomy. Methods: This is a pragmatic randomized controlled trial with blind assessors. The study will be conducted in the Breast Unit of Hospital Universitario Sagrado Corazon of Barcelona (Spain). A sample of 40 women will be recruited and randomized to receive acupuncture treatment in addition to standard care procedures, or standard care procedures alone. The main outcome, pain, will be assessed after the surgical intervention and 4, 10 and 30 days later using the numerical rating scale. Secondary outcomes include anxiety, use of analgesics, nausea, adverse effects, and surgical complications. Discussion: Acupuncture is a low-cost non-pharmacological strategy. This study will help to clarify its possible role in controlling post-mastectomy adverse effects.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2020

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 9, 2020

Completed
20 days until next milestone

First Posted

Study publicly available on registry

October 29, 2020

Completed
3 days until next milestone

Study Start

First participant enrolled

November 1, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

October 29, 2020

Status Verified

September 1, 2020

Enrollment Period

2 years

First QC Date

October 9, 2020

Last Update Submit

October 27, 2020

Conditions

Outcome Measures

Primary Outcomes (5)

  • Post-intervention pain at 12 hours after surgery

    Pain will be evaluated using the numerical rating scale (NRS). This measure uses a scale of 0 to 10 in which the higher values represent the most severe pain.

    12 hours after surgery (before the acupuncture treatment)

  • Post-intervention pain at 48 hours after surgery

    Pain will be evaluated using the numerical rating scale (NRS). This measure uses a scale of 0 to 10 in which the higher values represent the most severe pain.

    48 hours after surgery (after the acupuncture treatment)

  • Post-intervention pain at first out-patient visit

    Pain will be evaluated using the numerical rating scale (NRS). This measure uses a scale of 0 to 10 in which the higher values represent the most severe pain.

    In the first out-patient visit between 10 and 12 days after the intervention (evaluated before the acupuncture session)

  • Analgesic compsumption during hospital stay

    Amount of analgesic medication administered (ex: mg)

    During the hospital stay

  • Analgesic compsumption at home

    Amount of analgesic medication administered (ex: mg)

    From discharge until day 15 after surgery.

Secondary Outcomes (8)

  • Anxiety at 12 hours

    Evaluations will be made 12 hours after the intervention

  • Anxiety at 48 hours

    Evaluations will be made 48 hours after the intervention

  • Anxiety at first visit

    Evaluations will be made at first visit, between 10 and 12 days after the intervention.

  • Anxiety at one month

    Evaluations will be made at one month after surgery.

  • Postoperative nausea after surgery

    At 12 hours after surgery

  • +3 more secondary outcomes

Study Arms (2)

Acupuncture group

EXPERIMENTAL

The experimental group will receive the standard treatment administered in these cases (analgesic regimen and nursing care procedures), in addition to the following acupuncture therapy. In the first visit (preoperative), the anamnesis and energy diagnosis of each patient will be carried out following the practices of Traditional Chinese Medicine (TCM) to design a personalized treatment based on the patient's medical history. A treatment of approximately 10 to 12 acupuncture points will be designed considering the TCM diagnosis and medical history of each patient. Both TCM diagnosis and the points used will be reassessed in each session. The points belonging to the upper extremity of the affected breast will be treated on the contralateral side, taking care not to insert any needle in the limb on the affected side. No points in the operated region will be used.

Other: Acupuncture

Control group

NO INTERVENTION

The control group will only receive standard care procedures (analgesic regimen and nursing care procedures), although they will have the same follow up visits as the patients in the intervention group to facilitate analysis of the study variables.

Interventions

Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. It is sometimes used in conjunction with heat, moxibustion, acupressure, or electric stimulation.

Acupuncture group

Eligibility Criteria

Age20 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of breast cancer
  • Primary breast cancer patient
  • Candidate for breast cancer surgery (mastectomy)
  • Aged between 20 and 70 years old
  • Consenting to participate in the study and signing the informed consent form.

You may not qualify if:

  • Have a previous history of breast cancer
  • Have a previous diagnosis of a severe psychiatric disorder
  • Present risk factors associated with breast cancer
  • Do not speak Spanish or Catalan
  • Are currently participating in another trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Central Study Contacts

Carles Fernández, Phusical Terapist

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 9, 2020

First Posted

October 29, 2020

Study Start

November 1, 2020

Primary Completion

November 1, 2022

Study Completion

March 1, 2023

Last Updated

October 29, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share